| Full Name | Wesley Dean |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 161 Jackson St, Lowell, Massachusetts |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063036994 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | MT221368 (Pennsylvania) | Secondary |
| 208000000X | Pediatrics | 1013772 (Massachusetts) | Primary |
| Entity Name | Atrius Health Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871639914 PECOS PAC ID: 4789588641 Enrollment ID: O20031121000582 |
News Archive
Ghrelin is a hormone released by the lining of the stomach that promotes feeding behavior. Decreasing ghrelin levels could potentially help combat obesity - in fact, a vaccine that lowers ghrelin levels in order to reduce appetite is being studied as a treatment for obesity.
Chronic use of prescription painkillers, also known as opioids, among obese patients prior to bariatric surgery continues after surgery, according to a new Kaiser Permanente study published today in the Journal of the American Medical Association.
The children of older mothers may have improved health and development up to 5 years of age, say researchers in the British Medical Journal.
Analysis of social media messages between care home staff on the coronavirus front line reveal their growing concerns over how to manage in the face of the virus. Thousands of Whatsapp messages between 250 care home workers during the first coronavirus wave show workers were often asking questions which went unanswered due to a lack of proper guidance.
New data have been presented for the first time at the European Association of Dermato Oncology (EADO) Congress today on the investigational MEK inhibitor cobimetinib (GDC-0973) in combination with BRAFV600 inhibitor Zelboraf® (vemurafenib) for metastatic melanoma, the most aggressive form of skin cancer. The findings illustrate that cobimetinib and vemurafenib can be safely co-administered and that the combination shows promising anti-tumour activity, with a median progression-free survival (mPFS) of 13.7 months for BRAF inhibitor-naive patients.1
› Verified 5 days ago
| Entity Name | Lowell Community Health Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952307530 PECOS PAC ID: 6204807944 Enrollment ID: O20040804001749 |
News Archive
Ghrelin is a hormone released by the lining of the stomach that promotes feeding behavior. Decreasing ghrelin levels could potentially help combat obesity - in fact, a vaccine that lowers ghrelin levels in order to reduce appetite is being studied as a treatment for obesity.
Chronic use of prescription painkillers, also known as opioids, among obese patients prior to bariatric surgery continues after surgery, according to a new Kaiser Permanente study published today in the Journal of the American Medical Association.
The children of older mothers may have improved health and development up to 5 years of age, say researchers in the British Medical Journal.
Analysis of social media messages between care home staff on the coronavirus front line reveal their growing concerns over how to manage in the face of the virus. Thousands of Whatsapp messages between 250 care home workers during the first coronavirus wave show workers were often asking questions which went unanswered due to a lack of proper guidance.
New data have been presented for the first time at the European Association of Dermato Oncology (EADO) Congress today on the investigational MEK inhibitor cobimetinib (GDC-0973) in combination with BRAFV600 inhibitor Zelboraf® (vemurafenib) for metastatic melanoma, the most aggressive form of skin cancer. The findings illustrate that cobimetinib and vemurafenib can be safely co-administered and that the combination shows promising anti-tumour activity, with a median progression-free survival (mPFS) of 13.7 months for BRAF inhibitor-naive patients.1
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Wesley Dean, MD 161 Jackson St, Lowell, MA 01852-2103 Ph: (978) 937-9700 | Wesley Dean, MD 161 Jackson St, Lowell, MA 01852 Ph: (978) 937-9700 |
News Archive
Ghrelin is a hormone released by the lining of the stomach that promotes feeding behavior. Decreasing ghrelin levels could potentially help combat obesity - in fact, a vaccine that lowers ghrelin levels in order to reduce appetite is being studied as a treatment for obesity.
Chronic use of prescription painkillers, also known as opioids, among obese patients prior to bariatric surgery continues after surgery, according to a new Kaiser Permanente study published today in the Journal of the American Medical Association.
The children of older mothers may have improved health and development up to 5 years of age, say researchers in the British Medical Journal.
Analysis of social media messages between care home staff on the coronavirus front line reveal their growing concerns over how to manage in the face of the virus. Thousands of Whatsapp messages between 250 care home workers during the first coronavirus wave show workers were often asking questions which went unanswered due to a lack of proper guidance.
New data have been presented for the first time at the European Association of Dermato Oncology (EADO) Congress today on the investigational MEK inhibitor cobimetinib (GDC-0973) in combination with BRAFV600 inhibitor Zelboraf® (vemurafenib) for metastatic melanoma, the most aggressive form of skin cancer. The findings illustrate that cobimetinib and vemurafenib can be safely co-administered and that the combination shows promising anti-tumour activity, with a median progression-free survival (mPFS) of 13.7 months for BRAF inhibitor-naive patients.1
› Verified 5 days ago
Daniel W Dubner, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 33 Bartlett St, Lowell, MA 01852 Phone: 978-452-2200 | |
Dr. Suparna Sharma, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 295 Varnum Ave, Lowell, MA 01854 Phone: 978-937-6000 | |
Mr. Stephen A Conway, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 33 Bartlett St, Suite 305, Lowell, MA 01852 Phone: 978-452-2200 Fax: 978-441-2651 | |
Cathleen Bonacci, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 597 Merrimack St, Lowell Community Health Center, Lowell, MA 01854 Phone: 978-937-9700 Fax: 978-446-9830 | |
Purnima Baranwal, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 597 Merrimack St, Lowell, MA 01854 Phone: 978-937-9700 | |
Dr. Kristen A Klemmer, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 295 Varnum Ave, Lowell, MA 01854 Phone: 978-937-6000 |